S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Soligenix Announces Publication Successfully Demonstrating Enhanced Immunogenicity of its Heat-Stable Anthrax Vaccine (2015/1/29)|
|Soligenix Announces Positive Preliminary Nonclinical Results in Macrophage Activation Syndrome (2015/1/5)|
|FDA Grants Soligenix "Fast Track" Designation for SGX301 for the First-Line Treatment of Cutaneous T-Cell Lymphoma (2015/1/7)|
|Soligenix to Present at the 17th Annual BIO CEO & Investor Conference in New York City (2015/2/5)|
|Preclinical Melioidosis Results Presented at the 2015 ASM Biodefense and Emerging Diseases Research Meeting in Washington, DC (2015/2/11)|
|Soligenix Announces Publication of Combination Ricin/Anthrax Vaccine Data (2014/12/29)|
|Soligenix Announces Presentation and Poster at the 2015 ASM Biodefense and Emerging Diseases Research Meeting in Washington, DC (2015/2/2)|
|Ricin Toxin Vaccine Poster Presented at the 2015 ASM Biodefense and Emerging Diseases Research Meeting in Washington, DC (2015/2/13)|
Click above to view more mutual fund data and stats for sngx - Soligenix Inc.